Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 3451 AL 3465

Response to: Anesthetic Effect on the Subthalamic Nucleus in Microelectrode Recording and Local Field Potential of Parkinson's Disease

Diogo C, Conner CR.

Neuromodulation. 2025 Jun;28(4):705-706. doi: 10.1016/j.neurom.2025.03.066.

Neurological Inflammation in Parkinsonism: Current Prognosticative Diagnostics and Pitfalls

Lakshmipriya T, Gopinath SCB, Chen Y, Sasidharan S, Salim ET, Fakhri MA.

Curr Top Med Chem. 2025;26(2):103-114. doi: 10.2174/0115680266365134250530063901.

Exploring the landscape of Parkinson's disease transcriptomics: a quantitative review of research progress and future directions

Wang Y, Li T, Zhang X, Tai H, Li W, Su B.

Front Aging Neurosci. 2025 May 21;17:1505374. doi: 10.3389/fnagi.2025.1505374. eCollection 2025.

Recent advances (2022-2024) in eye-tracking for Parkinson's disease: a promising tool for diagnosing and monitoring symptoms

Culicetto L, Cardile D, Marafioti G, Lo Buono V, Ferraioli F, Massimino S, Di Lorenzo G, Sorbera C, Brigandì A, Vicario CM, Quartarone A, Marino S.

Front Aging Neurosci. 2025 May 21;17:1534073. doi: 10.3389/fnagi.2025.1534073. eCollection 2025.

Late onset epilepsy and dementia with Lewy bodies: Underestimated association?

Porché M, Dumurgier J, Hourrègue C, Paquet C.

J Alzheimers Dis Rep. 2025 Jun 2;9:25424823251328613. doi: 10.1177/25424823251328613. eCollection 2025 Jan-Dec.

Regulation of polyamine interconversion enzymes affects α-Synuclein levels and toxicity in a Drosophila model of Parkinson's Disease

Ranxhi B, Bangash ZR, Chbihi ZM, Qadri Z, Islam NN, Todi SV, LeWitt PA, Tsou WL.

Res Sq [Preprint]. 2025 May 15:rs.3.rs-6648986. doi: 10.21203/rs.3.rs-6648986/v1.

Pain in Parkinson's disease is impacted by motor complications, anxiety and sleep disturbances

Rukavina K, Staunton J, Zinzalias P, Skoric MK, Poplawska-Domaszewicz K, Pisani A, Bannister K, Chaudhuri KR.

Eur J Pain. 2025 Feb;29(2):e4765. doi: 10.1002/ejp.4765.

Vascular parkinsonism: an update

Jellinger KA.

J Neural Transm (Vienna). 2025 Jul;132(7):899-919. doi: 10.1007/s00702-025-02960-w. Epub 2025 Jun 5.

Recent advances in the genetics of Parkinson's disease in underrepresented populations

Marconi GA, Teixeira-Dos-Santos D, Schuh AFS.

Curr Opin Neurol. 2025 Aug 1;38(4):349-354. doi: 10.1097/WCO.0000000000001391. Epub 2025 Jun 5.

The relation between proprioceptive ability and physical function in people with stroke, Parkinson's disease, and multiple sclerosis: a systematic review

Robertson LS, Fisher G, Diong J, Butler AA, Gandevia SC, Héroux ME.

J Appl Physiol (1985). 2025 Jul 1;139(1):167-184. doi: 10.1152/japplphysiol.00088.2025. Epub 2025 Jun 5.

The Performance of Biomarkers for the Diagnosis of Parkinson Disease: A Systematic Review

Lim J, Ay Y.

Am J Med. 2025 Dec;138(12):1662-1670.e4. doi: 10.1016/j.amjmed.2025.05.047. Epub 2025 Jun 3.

BDNF biosensors for neurodegenerative disease

Saeed TN, Al-Hussainy AF, Sanghvi G, Ballal S, Singh A, Sabarivani A, Mishra S, Rizaev J, Taher SG, Alwan M, Jawad M, Mushtaq H.

Clin Chim Acta. 2025 Aug 15;576:120412. doi: 10.1016/j.cca.2025.120412. Epub 2025 Jun 3.

Targeting of the PI3 K/AKT/GSK3β Pathway in Parkinson's Disease: A Therapeutic Blueprint

AlRuwaili R, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Alexiou A, Papadakis M, Fetoh MEA, Batiha GE.

Mol Neurobiol. 2025 Nov;62(11):15108-15131. doi: 10.1007/s12035-025-05113-y. Epub 2025 Jun 5.

Expert perspectives on the use of safinamide for Parkinson's disease in Portugal: insights from a Portuguese Delphi Consensus

Rodrigues AM, Costa C, Gago M, Grunho M, Guedes LC, Morgadinho A, Rosas MJ, Simões R, Velon AG.

J Comp Eff Res. 2025 Jul;14(7):e240228. doi: 10.57264/cer-2024-0228. Epub 2025 Jun 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias